# MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer

> **NCT00401492** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute, Naples** · enrollment: 159 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** gemcitabine prolonged continuous infusion
- **DRUG:** cisplatin
- **DRUG:** vinorelbine

## Key facts

- **NCT ID:** NCT00401492
- **Lead sponsor:** National Cancer Institute, Naples
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2006-12
- **Final completion:** 2007-04
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2012-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00401492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00401492, "MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00401492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*